Patent assignee · CA · COMPANY

ARBUTUS BIOPHARMA CORPORATION

58Patents
56Active
58Granted
56Portfolio score

Filing activity: Dec 7, 2010 → Jan 12, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US9394234B2 Lipid formulations Emerging Cross-Sectional Technologies 99 Active
US9682139B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 28 Active
US11141378B2 Lipid formulations for nucleic acid delivery Chemistry; Metallurgy 28 Active
US9636301B2 In vitro release assay for liposome encapsulated vincristine Physics 27 Active
US10653780B2 Amino lipids and methods for the delivery of nucleic acids Emerging Cross-Sectional Technologies 18 Active
US9687550B2 Compositions for nucleic acid delivery Chemistry; Metallurgy 12 Active
US10077232B2 Cyclic cationic lipids and methods of use Chemistry; Metallurgy 12 Active
US10117941B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 10 Active
US10053689B2 Methods for increasing efficacy of lipid formulated siRNA Chemistry; Metallurgy 7 Active
US9764036B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 7 Active
US10415037B2 Compositions and methods for silencing hepatitis B virus gene expression Chemistry; Metallurgy 7 Active
US9814777B2 Targeting lipids Emerging Cross-Sectional Technologies 7 Active
US10456473B2 Lipid compositions Emerging Cross-Sectional Technologies 6 Active
US10561732B2 Trialkyl cationic lipids and methods of use thereof Chemistry; Metallurgy 4 Active
US11191849B2 Compositions and methods for delivering messenger RNA Chemistry; Metallurgy 4 Active
US10821186B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 4 Active
US9707292B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 4 Active
US11718852B2 Non-liposomal systems for nucleic acid delivery Chemistry; Metallurgy 3 Active
US9694077B2 Lipid compositions Emerging Cross-Sectional Technologies 3 Active
US11446383B2 Lipid formulations for delivery of therapeutic agents Emerging Cross-Sectional Technologies 3 Active
US11786598B2 Lipid formulations for delivery of therapeutic agents Emerging Cross-Sectional Technologies 3 Active
US10358447B2 Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same Human Necessities 2 Active
US9895448B2 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components Chemistry; Metallurgy 2 Active
US11077197B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 2 Active
US11427823B2 Targeted compositions Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.